A detailed history of Edmond De Rothschild Holding S.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 103,957 shares of LLY stock, worth $82.7 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
103,957
Previous 100,104 3.85%
Holding current value
$82.7 Million
Previous $90.6 Million 1.62%
% of portfolio
1.53%
Previous 1.58%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $2.98 Million - $3.7 Million
3,853 Added 3.85%
103,957 $92.1 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $31.7 Million - $39.7 Million
43,717 Added 77.53%
100,104 $90.6 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $1.09 Million - $1.46 Million
1,849 Added 3.39%
56,387 $43.9 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $14.9 Million - $17.5 Million
-28,290 Reduced 34.16%
54,538 $31.8 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $1.11 Million - $1.54 Million
2,563 Added 3.19%
82,828 $44.5 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $5.53 Million - $7.4 Million
15,770 Added 24.45%
80,265 $37.6 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $1.16 Million - $1.37 Million
-3,743 Reduced 5.49%
64,495 $22.1 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $1.37 Million - $1.6 Million
4,275 Added 6.68%
68,238 $25 Million
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $1.56 Million - $1.78 Million
-5,276 Reduced 7.62%
63,963 $20.7 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $4.77 Million - $5.6 Million
-17,111 Reduced 19.82%
69,239 $22.4 Million
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $1.79 Million - $2.22 Million
-7,621 Reduced 8.11%
86,350 $24.7 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $3.54 Million - $4.39 Million
-15,740 Reduced 14.35%
93,971 $26 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $745,019 - $916,851
-3,362 Reduced 2.97%
109,711 $25.3 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $108,330 - $140,124
600 Added 0.53%
113,073 $26 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $2.46 Million - $3.19 Million
-14,987 Reduced 11.76%
112,473 $21 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $12.7 Million - $16.8 Million
97,460 Added 324.87%
127,460 $21.5 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $4.39 Million - $5.07 Million
30,000 New
30,000 $4.44 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $211,800 - $237,280
-2,000 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $378,500 - $434,400
-5,000 Reduced 71.43%
2,000 $171,000
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $539,490 - $598,780
7,000
7,000 $599,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.